Non-cell-autonomous manner of AAV administration to attenuate cardiomyocyte hypertrophy by targeting paracrine signaling on ECM to reduce viral dosage.
Lei LiuPeng YueYue ZhangYimin HuaWenwei BiHualin YanHongyu LiaoJiawen LiKaiyu ZhouYifei LiPublished in: Signal transduction and targeted therapy (2022)